Binding of C4b-binding protein to porin: a molecular mechanism of serum resistance of Neisseria gonorrhoeae

We screened 29 strains of Neisseria gonorrhoeae and found 16/21 strains that resisted killing by normal human serum and 0/8 serum sensitive strains that bound the complement regulator, C4b-binding protein (C4bp). Microbial surface–bound C4bp demonstrated cofactor activity. We constructed gonococcal strains with hybrid porin (Por) molecules derived from each of the major serogroups (Por1A and Por1B) of N. gonorrhoeae, and showed that the loop 1 of Por1A is required for C4bp binding. Por1B loops 5 and 7 of serum-resistant gonococci together formed a negatively charged C4bp-binding domain. C4bp–Por1B interactions were ionic in nature (inhibited by high salt or by heparin), whereas the C4bp–Por1A bond was hydrophobic. Only recombinant C4bp mutant molecules containing the NH2-terminal α-chain short consensus repeat (SCR1) bound to both Por1A and Por1B gonococci, suggesting that SCR1 contained Por binding sites. C4bp α-chain monomers did not bind gonococci, indicating that the polymeric form of C4bp was required for binding. Using fAb fragments against C4bp SCR1, C4bp binding to Por1A and Por1B strains was inhibited in a complement-dependent serum bactericidal assay. This resulted in complete killing of these otherwise fully serum resistant strains in only 10% normal serum, underscoring the importance of C4bp in mediating gonococcal serum resistance.

[1]  M. Ward,et al.  Gonococci in Urethral Exudates possess a Virulence Factor lost on Subculture , 1970, Nature.

[2]  L. Lee,et al.  Secretory IgA antibody responses to Neisseria gonorrhoeae in the genital secretions of infected females. , 1976, The Journal of infectious diseases.

[3]  V. Nussenzweig,et al.  Human C4-binding protein. I. Isolation and characterization , 1978, The Journal of experimental medicine.

[4]  V. Nussenzweig,et al.  Human C4-binding protein. II. Role in proteolysis of C4b by C3b- inactivator , 1978, The Journal of experimental medicine.

[5]  G. Brooks,et al.  Serum bactericidal action and activation of the classic and alternate complement pathways by Neisseria gonorrhoeae. , 1978, The Journal of laboratory and clinical medicine.

[6]  V. Nussenzweig,et al.  Presence of a C4-Binding Protein (C4-bp) in Human Serum , 1978 .

[7]  G. Mcneillage,et al.  Secretory antibody response of the cervix to infection with Neisseria gonorrhoeae. , 1979, The British journal of venereal diseases.

[8]  C. Penn,et al.  Phenotypically determined resistance of Neisseria gonorrhoeae to normal human serum: environmental factors in subcutaneous chambers in guinea pigs. , 1979, Journal of general microbiology.

[9]  B. Boettcher,et al.  The presence of complement in human cervical mucus and its possible relevance to infertility in women with complement-dependent sperm-immobilizing antibodies. , 1979, Fertility and sterility.

[10]  V. Nussenzweig,et al.  The role of C4-binding protein and {beta }1H in proteolysis of C4b and C3b , 1979, The Journal of experimental medicine.

[11]  V. Nussenzweig,et al.  Modulation of the classical pathway C3 convertase by plasma proteins C4 binding protein and C3b inactivator. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[12]  D. Kasper,et al.  Natural serum bactericidal activity against Neisseria gonorrhoeae isolates from disseminated, locally invasive, and uncomplicated disease. , 1980, Journal of immunology.

[13]  H. Smith,et al.  Induction of phenotypically determined resistance of Neisseria gonorrhoeae to human serum by factors in human serum. , 1981, Journal of general microbiology.

[14]  H. Nikaido,et al.  Protein I of Neisseria gonorrhoeae outer membrane is a porin , 1981 .

[15]  C. Penn,et al.  Factors affecting the induction of phenotypically determined serum resistance of Neisseria gonorrhoeae grown in media containing serum or its diffusible components. , 1981, Journal of general microbiology.

[16]  T. Meyer,et al.  Pilus expression in neisseria gonorrhoeae involves chromosomal rearrangement , 1982, Cell.

[17]  G. Pier,et al.  Immunological basis of serum resistance of Neisseria gonorrhoeae. , 1982, Journal of general microbiology.

[18]  J. Cannon,et al.  Confirmation of association of protein I serotype of Neisseria gonorrhoeae with ability to cause disseminated infection , 1983, Infection and immunity.

[19]  P. Rice,et al.  Disseminated Gonococcal Infection: A Prospective Analysis of 49 Patients and a Review of Pathophysiology and Immune Mechanisms , 1983, Medicine.

[20]  T. Koide,et al.  Human C4b‐binding protein, C4bp , 1983, FEBS letters.

[21]  B. Dahlbäck Purification of human C4b-binding protein and formation of its complex with vitamin K-dependent protein S. , 1983, The Biochemical journal.

[22]  C. Smith,et al.  Visualization of human C4b-binding protein and its complexes with vitamin K-dependent protein S and complement protein C4b. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[23]  K. Holmes,et al.  Serological classification of Neisseria gonorrhoeae with use of monoclonal antibodies to gonococcal outer membrane protein I. , 1984, The Journal of infectious diseases.

[24]  B. Dahlbäck,et al.  Ultrastructure of C4b-binding protein fragments formed by limited proteolysis using chymotrypsin. , 1984, The Journal of biological chemistry.

[25]  G. Schoolnik,et al.  Antibody-antigen specificity in the immune response to infection with Neisseria gonorrhoeae. , 1985, Journal of Infectious Diseases.

[26]  F. Plummer,et al.  Correlation of auxotype and protein I type with expression of disease due to Neisseria gonorrhoeae. , 1985, The Journal of infectious diseases.

[27]  J. Griffiss,et al.  Elaboration of a 3.6-kilodalton lipooligosaccharide, antibody against which is absent from human sera, is associated with serum resistance of Neisseria gonorrhoeae , 1985, Infection and immunity.

[28]  P. Rice,et al.  Bactericidal antibody response of normal human serum to the lipooligosaccharide of Neisseria gonorrhoeae. , 1986, The Journal of infectious diseases.

[29]  K. Holmes,et al.  Epidemiological analysis of Neisseria gonorrhoeae in the Federal Republic of Germany by auxotyping and serological classification using monoclonal antibodies. , 1986, Genitourinary medicine.

[30]  P. Densen,et al.  Specificity of antibodies against Neisseria gonorrhoeae that stimulate neutrophil chemotaxis. Role of antibodies directed against lipooligosaccharides. , 1987, The Journal of clinical investigation.

[31]  M. Inouye Bacterial outer membranes as model systems , 1987 .

[32]  E. Gotschlich,et al.  Characterization and specificity of antibodies to protein I of Neisseria gonorrhoeae produced by injection with various protein I- adjuvant preparations , 1988, The Journal of experimental medicine.

[33]  J. Poolman Gonococci and Meningococci , 1988, Springer Netherlands.

[34]  G. Nemerow,et al.  Epstein-Barr virus regulates activation and processing of the third component of complement , 1988, The Journal of experimental medicine.

[35]  M. Apicella,et al.  Selection and immunochemical analysis of lipooligosaccharide mutants of Neisseria gonorrhoeae , 1988, Infection and immunity.

[36]  N. Carbonetti,et al.  Genetics of protein I of Neisseria gonorrhoeae: construction of hybrid porins. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[37]  B. Dahlbäck,et al.  Novel subunit in C4b-binding protein required for protein S binding. , 1988, The Journal of biological chemistry.

[38]  G. Schumacher Immunology of spermatozoa and cervical mucus. , 1988, Human reproduction.

[39]  J. Cole,et al.  Cytidine 5'-monophospho-N-acetyl neuraminic acid and a low molecular weight factor from human blood cells induce lipopolysaccharide alteration in gonococci when conferring resistance to killing by human serum. , 1988, Microbial pathogenesis.

[40]  J. Cole,et al.  Cytidine 5'-monophospho-N-acetylneuraminic acid or a related compound is the low Mr factor from human red blood cells which induces gonococcal resistance to killing by human serum. , 1988, Journal of general microbiology.

[41]  L Slaney,et al.  Epidemiologic evidence for the development of serovar-specific immunity after gonococcal infection. , 1989, The Journal of clinical investigation.

[42]  E. Gotschlich,et al.  The construction and characterization of Neisseria gonorrhoeae lacking protein III in its outer membrane , 1989, Journal of Experimental Medicine.

[43]  S. Ho,et al.  Site-directed mutagenesis by overlap extension using the polymerase chain reaction. , 1989, Gene.

[44]  T. Aso,et al.  Molecular cloning of the cDNA coding for proline-rich protein (PRP): identity of PRP as C4b-binding protein. , 1989, Biochemical and biophysical research communications.

[45]  S. E. West,et al.  Genetic loci and linkage associations in Neisseria gonorrhoeae and Neisseria meningitidis , 1989, Clinical Microbiology Reviews.

[46]  T. Hackeng,et al.  Identification of Different Forms of Human C4b-Binding Protein Lacking β-Chain and Protein S Binding Ability , 1990, Thrombosis and Haemostasis.

[47]  M. Dominguez-Bello,et al.  Degradation of mimosine, 2,3-dihydroxy pyridine and 3-hydroxy-4(1H)-pyridine by bacteria from the rumen of sheep in Venezuela , 1990 .

[48]  C. Elkins,et al.  Construction of isogenic gonococci with variable porin structure: effects on susceptibility to human serum and antibiotics , 1990, Molecular microbiology.

[49]  M. Wilson,et al.  Modification by sialic acid of Neisseria gonorrhoeae lipooligosaccharide epitope expression in human urethral exudates: an immunoelectron microscopic analysis. , 1990, The Journal of infectious diseases.

[50]  E. Giovanetti,et al.  Antibiotic resistance in foodborne listeria , 1991, The Lancet.

[51]  J. Sarwar,et al.  Strain-specific and immunodominant surface epitopes of the P2 porin protein of nontypeable Haemophilus influenzae , 1991, Infection and immunity.

[52]  A. Kéchrid [Sensitivity of Neisseria gonorrhoeae to antibiotics]. , 1991, Archives de l'Institut Pasteur de Tunis.

[53]  P. Lambden,et al.  Sequence analysis and relationships between meningococcal class 3 serotype proteins and other porins from pathogenic and non-pathogenic Neisseria species. , 1992, FEMS microbiology letters.

[54]  H. Young,et al.  A serovar analysis of heterosexual gonorrhoea in Edinburgh 1986-90. , 1992, Genitourinary medicine.

[55]  D. Stirewalt,et al.  Antibodies to N‐terminal peptides of gonococcal porin are bactericidal when gonococcal lipopolysaccharide is not sialylated , 1992, Molecular microbiology.

[56]  F. Plummer,et al.  Bacterial antigenic variation, host immune response, and pathogen-host coevolution , 1993, Infection and immunity.

[57]  J. Griffiss,et al.  The structure of lipooligosaccharide produced by Neisseria gonorrhoeae, strain 15253, isolated from a patient with disseminated infection. Evidence for a new glycosylation pathway of the gonococcal lipooligosaccharide. , 1994, The Journal of biological chemistry.

[58]  C. Elkins,et al.  Cloning and constitutive expression of structural genes encoding gonococcal porin protein in Escherichia coli and attenuated Salmonella typhimurium vaccine strains. , 1994, Gene.

[59]  A. Campana,et al.  Investigations on the cell type responsible for the endometrial secretion of complement component 3 (C3). , 1994, Human reproduction.

[60]  P. Zipfel,et al.  Complement factor H and related proteins: an expanding family of complement-regulatory proteins? , 1994, Immunology today.

[61]  S. Gulati,et al.  Complement-mediated bacterial killing assays. , 1994, Methods in enzymology.

[62]  B. Spratt,et al.  Sequence evolution of the porB gene of Neisseria gonorrhoeae and Neisseria meningitidis: evidence of positive Darwinian selection. , 1995, Molecular biology and evolution.

[63]  M. Weir,et al.  Gonococcal serovar patterns in Glasgow: 1990-1992. , 1995, British journal of biomedical science.

[64]  G. Lindahl,et al.  Ig-binding surface proteins of Streptococcus pyogenes also bind human C4b-binding protein (C4BP), a regulatory component of the complement system. , 1995, Journal of immunology.

[65]  E. Johnsson,et al.  A highly variable region in members of the streptococcal M protein family binds the human complement regulator C4BP. , 1996, Journal of immunology.

[66]  K. Isaacson,et al.  Localization of the expression of complement component 3 in the human endometrium by in situ hybridization. , 1996, The Journal of clinical endocrinology and metabolism.

[67]  J. Lupski,et al.  Rapid determination of outbreak-related strains of Neisseria meningitidis by repetitive element-based polymerase chain reaction genotyping. , 1996, The Journal of infectious diseases.

[68]  T. Murphy,et al.  Mechanisms of Recurrent Otitis Media: Importance of the Immune Response to Bacterial Surface Antigens a , 1997, Annals of the New York Academy of Sciences.

[69]  F. Mooi,et al.  Bordetella pertussis binds the human complement regulator C4BP: role of filamentous hemagglutinin , 1997, Infection and immunity.

[70]  B. Dahlbäck,et al.  The amino-terminal module of the C4b-binding protein alpha-chain is crucial for C4b binding and factor I-cofactor function. , 1997, The Biochemical journal.

[71]  D. Dorward,et al.  Porin polypeptide contributes to surface charge of gonococci , 1997, Journal of bacteriology.

[72]  J. Atkinson,et al.  Membrane cofactor protein: importance of N- and O-glycosylation for complement regulatory function. , 1998, Journal of immunology.

[73]  S. Ram,et al.  A Novel Sialic Acid Binding Site on Factor H Mediates Serum Resistance of Sialylated Neisseria gonorrhoeae , 1998, The Journal of experimental medicine.

[74]  Binding of Complement Factor H to Loop 5 of Porin Protein 1A: A Molecular Mechanism of Serum Resistance of Nonsialylated Neisseria gonorrhoeae , 1998 .

[75]  K. Berggård,et al.  Role of the hypervariable region in streptococcal M proteins: binding of a human complement inhibitor. , 1998, Journal of immunology.

[76]  D. Covell,et al.  Structural investigation of C4b‐binding protein by molecular modeling: Localization of putative binding sites , 1998, Proteins.

[77]  P. Rice,et al.  Human immune response to monoclonal antibody — defined epitopes of Neisseria gonorrhoeae lipooligosaccharides , 1998 .

[78]  A. Blom,et al.  A Cluster of Positively Charged Amino Acids in the C4BP α-Chain Is Crucial for C4b Binding and Factor I Cofactor Function* , 1999, The Journal of Biological Chemistry.

[79]  R. Brunham,et al.  Genetic Diversity and Mosaicism at the por Locus ofNeisseria gonorrhoeae , 1999, Journal of bacteriology.

[80]  T. Heeren,et al.  Complement processing and immunoglobulin binding to Neisseria gonorrhoeae determined in vitro simulates in vivo effects. , 1999, The Journal of infectious diseases.

[81]  M. Hobbs,et al.  Molecular typing of Neisseria gonorrhoeae causing repeated infections: evolution of porin during passage within a community. , 1999, The Journal of infectious diseases.

[82]  S. Meri,et al.  The factor H protein family. , 1999, Immunopharmacology.

[83]  D. Weiner,et al.  Longitudinal evaluation of serovar-specific immunity to Neisseria gonorrhoeae. , 1999, American journal of epidemiology.

[84]  A. Blom,et al.  Human C4b-Binding Protein Has Overlapping, But Not Identical, Binding Sites for C4b and Streptococcal M Proteins1 , 2000, The Journal of Immunology.

[85]  F. Babl,et al.  Neonatal gonococcal arthritis after negative prenatal screening and despite conjunctival prophylaxis. , 2000, The Pediatric infectious disease journal.

[86]  D. Pérez-Caballero,et al.  Assessment of the interaction of human complement regulatory proteins with group A Streptococcus. Identification of a high‐affinity group A Streptococcus binding site in FHL‐1 , 2000, European journal of immunology.